23andMe Investor Relations Material
Latest events
Q2 2025
23andMe
Q4 2025
10 Jun, 2025
Investor Presentation
7 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 23andMe Holding Co
Access all reports
23andMe Holding Co. operates as a consumer genetics and research company, which engages in the provision of genetic testing services using direct-to-consumer DNA kits. It offers personal genetic information about an individual's ancestry, genealogy, and inherited traits. The company was founded by Linda Avey and Paul Cusenza in October 2006 and is headquartered in Mountain View, CA.
Key slides for 23andMe Holding Co
Investor Presentation
23andMe Holding Co
Investor Presentation
23andMe Holding Co
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
ME
Country
🇺🇸 United States